Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Annals of Hematology
|
March 22, 2002
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases
M Kornacker, A Kraemer, E Leo, et al.
European Journal of Haematology
|
February 8, 2005
Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases
M Kornacker, T Luft, A D Ho, et al.
Cancer Immunology, Immunotherapy : CII
|
August 18, 2000
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis
M R Verneris, M Kornacker, V Mailänder, et al.
Immunology Letters
|
April 18, 2001
Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells
M Kornacker, M R Verneris, B Kornacker, et al.
Cytotherapy
|
April 22, 2006
The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab
M Kornacker, Mr Verneris, B Kornacker, et al.
Annals of Hematology
|
July 19, 2008
Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma
M Kornacker, B Kornacker, C Schmitt, et al.
British Journal of Haematology
|
August 25, 1999
Detection of a Hodgkin/Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease
M Kornacker, A Jox, M Vockerodt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 1998
Detection of identical Hodgkin-Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later
A Jox, T Zander, M Kornacker, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 2011
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
B Schultheis, G Kummer, M Zeth, et al.
Blood
|
May 26, 1999
Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells
A Jox, T Zander, R Küppers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Annals of Hematology
|
March 22, 2002
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases
M Kornacker, A Kraemer, E Leo, et al.
European Journal of Haematology
|
February 8, 2005
Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases
M Kornacker, T Luft, A D Ho, et al.
Cancer Immunology, Immunotherapy : CII
|
August 18, 2000
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis
M R Verneris, M Kornacker, V Mailänder, et al.
Immunology Letters
|
April 18, 2001
Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells
M Kornacker, M R Verneris, B Kornacker, et al.
Cytotherapy
|
April 22, 2006
The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab
M Kornacker, Mr Verneris, B Kornacker, et al.
Annals of Hematology
|
July 19, 2008
Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma
M Kornacker, B Kornacker, C Schmitt, et al.
British Journal of Haematology
|
August 25, 1999
Detection of a Hodgkin/Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease
M Kornacker, A Jox, M Vockerodt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 1998
Detection of identical Hodgkin-Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later
A Jox, T Zander, M Kornacker, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 2011
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
B Schultheis, G Kummer, M Zeth, et al.
Blood
|
May 26, 1999
Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells
A Jox, T Zander, R Küppers, et al.
Page
of 2